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Abstract
Compliance with anti-psychotic medications plays a
significant role in managing clients with schizophrenia. It
not only helps in controlling the symptoms, but also
decreases the risk of relapses and ultimately improves
quality of life (QoL) for the clients. However, compliance
with anti-psychotic medication remains a challenge for
the client, family and healthcare providers. Identification
of these associated factors is vital to make appropriate
plan to enhance medication compliance. In this paper,
various factors are highlighted that are associated with
medication compliance in clients with schizophrenia.
Keywords: Schizophrenia, Anti-psychotic medications,
Non- compliance, Relapse, Insight.
Introduction
Compliance with medication remains a challenge in
psychiatry globally. Mostly, chronic mentally ill clients
such as schizophrenics are managed acutely in hospital
settings, but their home management and treatment
compliance remain doubtful. Schizophrenia is a persistent
disease of disconnected mind1 that results in progressive
clinical, cognitive, social and vocational deterioration.1 It
is apparently the most expensive psychiatric illness that
causes a huge economic burden on client, family and
nation.2 Therefore, long-term management of
schizophrenia with anti-psychotic medication is
considered a cost-effective approach for developing
countries.3
Though the anti-psychotic drugs are considered foremost
for the treatment of schizophrenia,1 compliance with
medications remains a concern.3 A study reported that
74% of the patients with chronic schizophrenia stopped
taking their medication within 18 months.4 A study
conducted in Pakistan also reported that 41.8% of the
patients with psychotic illness were identified to be non-
compliant.5 The major consequences reported to be
associated with the non-compliance includes worsening
of symptoms, increased risk of relapse, personal suffering,
re-hospitalisation and suicidal attempt, and increased
cost and disrupted process of recovery. The risk of relapse
increases almost five-fold due to non-compliance to
medications in schizophrenia.3,6 Hence, one of the major
contributions of the recovering client relies on
compliance with medication. This review aims at
recognising the crucial factors that are associated with
poor compliance that can assist in making appropriate
plan for managing clients with schizophrenia.
Methods and Results
A literature search was conducted related to publications
between January 2000 and December 2012 from PubMed
using key terms ‘antipsychotic medications’, ‘non-
compliance’, ‘non-adherence’, ‘relapse’ and ‘insight’ in
combination with ‘Schizophrenia.’ The search was further
supplemented by a textbook in Psychiatric Nursing1 along
with personal experience of the researchers. In addition,
the reference list of the searched articles was also used in
identifying related articles that may have been missed
during the search. A total of 100 articles were identified
related to the topic. Finally 9 articles and the text book
were considered for inclusion, based on its relevance to
the topic and limitation of the references to be cited by
the selected journal.
Risk factors for non-compliance
Literature reveals various factors associated with
medication non-compliance in schizophrenia. These
factors can be addressed at individual, family/community,
healthcare professional and treatment levels (Table).
Individual factors
Various individual demographic variables, including age,
gender and socio-economic and educational status can
influence adherence to medications in clients with
schizophrenia.6 Younger clients are more likely to be non-
compliant then the elderly;4 however, possible decline in
cognition and memory in the elderly may alter their
persistence of treatment in the longer run.7 On the other
hand, women are found to be more compliant then men.7
Cost associated with the medications and regular follow-
up exerts additional burden on the clients.8 Likewise, in
Pakistan, a study reported that 16.32% of the patients had
stopped taking medication mainly because they could
not afford to bear the cost.5 In addition, low educational
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status contributes to poor understanding of the trend of
the disease that consequently results in poor
development of insight and medication compliance.6
Other unhealthy practices in clients with schizophrenia,
such as substance abuse, including alcohol, nicotine,
cocaine and cannabis, can also add to the non-compliant
behaviour and are considered significant factors for
relapse.1,6 Literature reveals that clients with substance
abuse disorder are at higher risk for non-adherence.1
Some of the individual factors that are associated with
schizophrenia, such as positive and negative symptoms,
also influence medication compliance. Clients who
experience persecutory and grandiose delusions (positive
symptoms) are either reluctant to take medication or are
less interested in their treatment. It is usually observed in
everyday nursing practice that persecutory delusions
often restrict clients from taking medication when offered
by a caregiver with the fear of being poisoned. On the
other hand, clients with negative symptoms often
experience lack of motivation which leads to poor
compliance.1 Therefore, individual’s perception and
attitude is significant barrier to medication compliance,
which is often associated with symptoms and poor
knowledge about the pattern of schizophrenia.
Acceptance of the disease or presence of insight also
plays a crucial role towards medication adherence and
treatment compliance. Literature reveals that between
50% and 80% of the patients with schizophrenia either
lack partial or total insight of their mental disorder.9 In
contrast, patients with the absence of insight at times do
continue their medication as their cognitive impairment
and poor memory requires them to rely solely on their
clinician’s judgment3 or that of the caregivers.
Family/caregiver factors
Contribution of family, friends and community can play a
major role in maintaining medication compliance in
schizophrenia. The risk of non-compliance goes up three
times in clients who are not supported by their family for
treatment adherence.10 However, families are less
frequently involved in the planning of treatment10 by
healthcare professionals. Literature depicts that
assistance and supervision provided by family can
enhance medication compliance,7 which can improve
clinical outcome and decrease the rate of relapse.10 Poor
understanding of the client’s disease process further
worsens the persistent support that the client is looking
for. This poor knowledge and associated social and
cultural myths often make a family prone to looking for
alternating treatment options such as quacks and
traditional faith-healers to deal with mental illnesses.5 In
developing countries like Pakistan, preference of
treatment is usually given to traditional healers compared
to psychiatrists as it is less expensive and coincides with
their values and beliefs.5 This practice is more common in
the rural areas compared to the urban areas. It often
results in worsening the symptoms and gives
psychological trauma to clients when strict measures of
faith-healing are performed that often result in further
deterioration of the client’s symptoms.
Healthcare professional factors
Poor physician-patient relationship is significantly
associated with the non-compliance in schizophrenia,
including poor discharge planning and lack of followup
care. Physicians are often found to be providing
inadequate consultation time to their clients. Proper time
helps in assessing the clients’ compliance and concerns.
Complex prescription of medication at times becomes
challenging for the client and family to comprehend and
follow as required.5 With limited assessment, at times it is
challenging for the healthcare team to differentiate
between poor responses versus poor compliance to the
medication.5 In addition, insufficient information
provided about the need for long-term treatment hinders
continuity of medication because the improvement of the
symptoms are equated with termination of the illness.5
About 28% of the clients reported to be careless once
their symptoms improved with psychiatric medications as
they were not informed that the maintenance dose of
medications is required for relapse prevention.8 Similarly,
a study conducted in Karachi, revealed that the inability of
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Table: Factors affecting medication compliance.
Individual factors Family/caregiver factors Health care provider factors Treatment factors
 Age  Poor understanding of illness  Poor physician patient relationship Medication side effects
 Gender  Lack of support  Communication gap  Availability of medication
 Educational status  Social and cultural myths and values  Poor assessment and follow-up  Delay onset of therapeutic effects
 Economic status  Poor guidance for medication compliance  Cost of selected brand of medication
Misuse of illicit drugs  Complex medication prescription
 Symptoms of disease
 Lack of insight
the physician to explain the timings and dose of
medication resulted in non-compliance of medication in
92% of psychiatric patients.5 In addition, this
communication gap between the physician and client
also fails to consider the client’s lifestyle, availability of
physical and financial resources of the client that are
required for maintaining compliance.
Treatment factors
One of the factors associated with medication non-
adherence in schizophrenia are the side-effects of
medications experienced by the client.1,7 The common
misconceptions of physician is that the information about
side-effects can lead to non-compliance often restrict the
physicians from sharing the possible side-effects with the
clients.7 This usually results in poor compliance. Moreover,
at times clients and family expect these drugs to work as
a miracle pill1 as they are unaware that the anti-psychotic
medication usually has a delayed onset of therapeutic
effect.7 As a result, they often become non-compliant
considering it to be ineffective when their misperception
remains unaddressed by the healthcare providers. In
addition, medication is prescribed without considering
the cost and availability of the drugs which is an added
challenge in terms of compliance.8
Conclusion
Compliance with anti-psychotic drugs is an enormous
challenge in clients with schizophrenia. To ensure
compliance, it is crucial to identify factors associated with
non-compliance, and to address these factors to develop
a comprehensive treatment plan. To enhance
understanding of the contributing factors in specific
socio-cultural contexts, further researches need to be
conducted in Pakistan.
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